{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T15:39:49Z","timestamp":1763393989145,"version":"3.45.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["UKRI2441"],"award-info":[{"award-number":["UKRI2441"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024501","name":"Birmingham Health Partners","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100024501","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"DOI":"10.1038\/s41433-025-04116-2","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T15:36:20Z","timestamp":1763393780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Topical beta-blocker for managing refractory conjunctival pyogenic granuloma"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7556-5116","authenticated-orcid":false,"given":"Haneen Habib","family":"Alaali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saba","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1081-1141","authenticated-orcid":false,"given":"Darren S. J.","family":"Ting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"4116_CR1","first-page":"327","volume":"87","author":"AP Ferry","year":"1989","unstructured":"Ferry AP. Pyogenic granulomas of the eye and ocular adnexa: a study of 100 cases. Trans Am Ophthalmol Soc. 1989;87:327\u201343.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"4116_CR2","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.ophtha.2005.01.048","volume":"112","author":"GM Espinoza","year":"2005","unstructured":"Espinoza GM, Lueder GT. Conjunctival pyogenic granulomas after strabismus surgery. Ophthalmology. 2005;112:1283\u20136.","journal-title":"Ophthalmology"},{"key":"4116_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/jamaophthalmol.2017.0110","volume":"135","author":"I Oke","year":"2017","unstructured":"Oke I, Alkharashi M, Petersen RA, Ashenberg A, Shah AS. Treatment of ocular pyogenic granuloma with topical timolol. JAMA Ophthalmol. 2017;135:383\u20135.","journal-title":"JAMA Ophthalmol"},{"key":"4116_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/IOP.0000000000001116","volume":"34","author":"LN DeMaria","year":"2018","unstructured":"DeMaria LN, Silverman NK, Shinder R. Ophthalmic pyogenic granulomas treated with topical timolol-clinical features of 17 cases. Ophthalmic Plast Reconstr Surg. 2018;34:579\u201382.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"4116_CR5","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.4103\/ijo.IJO_2404_20","volume":"69","author":"H Jaiswal","year":"2021","unstructured":"Jaiswal H, Patidar N, Shah C, Singh R, Jain E, Piyush P. Topical timolol 0.5% as the primary treatment of ophthalmic pyogenic granuloma: a prospective, single-arm study. Indian J Ophthalmol. 2021;69:1155\u20131160.","journal-title":"Indian J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04116-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04116-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04116-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T15:36:21Z","timestamp":1763393781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04116-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":5,"alternative-id":["4116"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-04116-2","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"type":"print","value":"0950-222X"},{"type":"electronic","value":"1476-5454"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}